Eutylone
Designer drug of the cathinone class
From Wikipedia, the free encyclopedia
Eutylone (also known as β-keto-1,3-benzodioxolyl-N-ethylbutanamine, bk-EBDB, and N-ethylbutylone) is a stimulant and empathogenic drug of the phenethylamine, amphetamine, phenylisobutylamine, and cathinone families which was developed in the 1960s,[3][4] which is classified as a designer drug.[5] It was first reported to the EMCDDA in 2014 and became widespread internationally in 2019-2020 following bans on the related compound ephylone.[6][7][8][9] It is a synthetic cathinone.[9] In 2021, eutylone was the most common cathinone identified by the Drug Enforcement Administration in the United States.[10]
- None
- BR: Class F2 (Prohibited psychotropics)[1]
- CA: Schedule I
- DE: Anlage II (Authorized trade only, not prescriptible)
- UK: Class B
- US: Schedule I
- UN: Psychotropic Schedule II[2]
| Clinical data | |
|---|---|
| ATC code |
|
| Legal status | |
| Legal status |
|
| Identifiers | |
| |
| CAS Number |
|
| PubChem CID | |
| ChemSpider | |
| UNII |
|
| KEGG | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C13H17NO3 |
| Molar mass | 235.283 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
| | |
Pharmacology
| DAT | NET | SERT |
|---|---|---|
| 120 ± 10 | 1280 ± 140 | 690 ± 50 |
Legal status
Sweden's public health agency suggested classifying eutylone as a hazardous substance, on September 25, 2019.[11]
In the United States Eutylone is considered a schedule 1 controlled substance as a positional isomer of Pentylone.[12][13]